文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

2018-2019年出生儿童24月龄时疫苗接种覆盖率——美国国家儿童免疫调查,2019-2021年

Vaccination Coverage by Age 24 Months Among Children Born During 2018-2019 - National Immunization Survey-Child, United States, 2019-2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-01-13

本报告利用美国国家儿童免疫调查数据,描述2018-2019年出生儿童在24月龄时的疫苗接种覆盖率。与2016-2017年出生儿童相比,多数推荐疫苗的覆盖率有所提高;脊灰疫苗≥3剂、乙肝疫苗≥3剂、麻腮风疫苗≥1剂和水痘疫苗≥1剂的覆盖率均超过90%,而甲肝疫苗≥2剂覆盖率最低,为47.3%。疫情期间,生活在联邦贫困线以下或农村地区的儿童7种疫苗联合系列的覆盖率下降了4-5个百分点;按种族和民族、贫困状况、保险状况和居住地存在覆盖率差异。

要点

  • 2018-2019年出生儿童24月龄时,脊灰疫苗≥3剂覆盖率93.4%,乙肝疫苗≥3剂92.7%,麻腮风疫苗≥1剂91.6%,水痘疫苗≥1剂91.1%。
  • 甲肝疫苗≥2剂覆盖率最低,为47.3%。
  • 疫情期间,生活在联邦贫困线以下或农村地区的儿童7种疫苗联合系列覆盖率下降了4-5个百分点。

核心结论

  • 与2016-2017年出生儿童相比,2018-2019年出生儿童多数推荐疫苗的覆盖率有所提高。
  • 2020年3月或之后达到24月龄的儿童总体疫苗接种覆盖率与2020年3月之前达到24月龄的儿童相似或更高。
  • 持续存在的保险状况差异表明需要通过儿童疫苗计划改善疫苗可及性。
  • 提供者应在每次临床就诊时审查儿童接种史并推荐所需疫苗,并解决家长犹豫问题,以帮助减少差异。

研究设计与样本

  • 本报告利用国家儿童免疫调查-儿童数据,描述2018-2019年出生儿童在24月龄时的疫苗接种覆盖率。

主要发现

  • 脊灰疫苗≥3剂覆盖率93.4%,乙肝疫苗≥3剂覆盖率92.7%,麻腮风疫苗≥1剂覆盖率91.6%,水痘疫苗≥1剂覆盖率91.1%。
  • 甲肝疫苗≥2剂覆盖率最低,为47.3%。
  • 2020年3月或之后达到24月龄的儿童总体疫苗接种覆盖率与2020年3月之前达到24月龄的儿童相似或更高。
  • 疫情期间,生活在联邦贫困线以下或农村地区的儿童7种疫苗联合系列覆盖率下降了4-5个百分点。
  • 2018-2019年出生儿童中,按种族和民族、贫困状况、保险状况和都市统计区居住地观察到覆盖率差异;私营保险儿童覆盖率通常高于其他保险或无保险儿童。

关键数值与推荐

  • 免疫实践咨询委员会推荐在生命最初24个月内常规接种14种疾病的疫苗。
  • 脊灰疫苗≥3剂覆盖率93.4%,乙肝疫苗≥3剂覆盖率92.7%,麻腮风疫苗≥1剂覆盖率91.6%,水痘疫苗≥1剂覆盖率91.1%。
  • 甲肝疫苗≥2剂覆盖率最低,为47.3%。

临床怎么用

  • 提供者应在每次临床就诊时审查儿童接种史并推荐所需疫苗。
  • 提供者应解决家长犹豫问题,以帮助减少差异并确保所有儿童免受疫苗可预防疾病的侵害。
  • 持续存在的保险状况差异表明需要通过儿童疫苗计划改善疫苗可及性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Millions of young children are vaccinated safely in the United States each year against a variety of potentially dangerous infectious diseases (1). The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination against 14 diseases during the first 24 months of life* (2). This report describes vaccination coverage by age 24 months using data from the National Immunization Survey-Child (NIS-Child).† Compared with coverage among children born during 2016-2017, coverage among children born during 2018-2019 increased for a majority of recommended vaccines. Coverage was >90% for ≥3 doses of poliovirus vaccine (93.4%), ≥3 doses of hepatitis B vaccine (HepB) (92.7%), ≥1 dose of measles, mumps, and rubella vaccine (MMR) (91.6%), and ≥1 dose of varicella vaccine (VAR) (91.1%); coverage was lowest for ≥2 doses of hepatitis A vaccine (HepA) (47.3%). Vaccination coverage overall was similar or higher among children reaching age 24 months during March 2020 or later (during the COVID-19 pandemic) than among those reaching age 24 months before March 2020 (prepandemic); however, coverage with the combined 7-vaccine series§ among children living below the federal poverty level or in rural areas decreased by 4-5 percentage points during the pandemic (3). Among children born during 2018-2019, coverage disparities were observed by race and ethnicity, poverty status, health insurance status, and Metropolitan Statistical Area (MSA) residence. Coverage was typically higher among privately insured children than among children with other insurance or no insurance. Persistent disparities by health insurance status indicate the need to improve access to vaccines through the Vaccines for Children (VFC) program.¶ Providers should review children's histories and recommend needed vaccinations during every clinical encounter and address parental hesitancy to help reduce disparities and ensure that all children are protected from vaccine-preventable diseases.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Hill HA, Chen M, Elam-Evans LD, et al. Vaccination Coverage by Age 24 Months Among Children Born During 2018-2019 - National Immunization Survey-Child, United States, 2019-2021. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36634013. doi:10.15585/mmwr.mm7202a3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。